Wilate Purple Book BLA 125251

BLA number
125251
Proprietary names
Wilate
Proper names
von Willebrand Factor/Coagulation Factor VIII Complex (Human)
Applicant
Octapharma Pharmazeutika Produktionsges.m.b.H.
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Wilatevon Willebrand Factor/Coagulation Factor VIII Complex (Human)351(a)500IUFor InjectionIntravenousSingle-Dose VialRxLicensed2010-12-20
002Wilatevon Willebrand Factor/Coagulation Factor VIII Complex (Human)351(a)1000IUFor InjectionIntravenousSingle-Dose VialRxLicensed2010-12-20

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2024-04-01U001Wilate351(a)RxOctapharma Pharmazeutika Produktionsges.m.b.H.
2024-04-01U002Wilate351(a)RxOctapharma Pharmazeutika Produktionsges.m.b.H.
2021-05-01U001Wilate351(a)RxOctapharma Pharmazeutika Produktionsges.m.b.H.
2021-05-01U002Wilate351(a)RxOctapharma Pharmazeutika Produktionsges.m.b.H.
2020-08-01R001Wilate351(a)RxOctapharma Pharmazeutika Produktionsges.m.b.H.
2020-08-01R002Wilate351(a)RxOctapharma Pharmazeutika Produktionsges.m.b.H.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-08-01001Wilate351(a)RxLicensed2010-12-20
2020-08-01002Wilate351(a)RxLicensed2010-12-20